<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8 - K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): OCTOBER 7, 1997
---------------
GALILEO CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 04-2526583
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
0-11309
(Commission File Number)
GALILEO PARK, P. O. BOX 550, STURBRIDGE, MASSACHUSETTS 01566
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code (508) 347-9191
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
Item 5. OTHER INFORMATION
On October 7, 1997, the Registrant acquired all of the outstanding
shares of Leisegang Feinmechanik-Optik GmbH & Co. KG ("Leisegang
GmbH") for approximately $2,250,000 in cash effective as of October 1,
1997. Leisegang GmbH, located in Berlin, Germany, is a manufacturer
and distributor of colposcopes and accessories with annual sales of
approximately $3,000,000. The Registrant acquired Leisegang Medical,
Inc., the United States distributor of colposcopes manufactured by
Leisegang GmbH, in 1996.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
a) Financial Statements of Business Acquired
Not Applicable.
b) Pro Forma Financial Information
Not Applicable.
c) Exhibits
99.1 Press Release dated October 8, 1997.
2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GALILEO CORPORATION
Date: October 20, 1997 By: /s/ Josef W. Rokus
-------------------------------------
Josef W. Rokus
Vice President, Corporate Development
3
<PAGE> 4
INDEX TO EXHIBITS
EXHIBIT PAGE
------- ----
99.1 Press Release dated October 8, 1997. 5
4
<PAGE> 1
Exhibit 99.1
- --------------------------------------------------------------------------------
[GALILEO NEWS LETTERHEAD]
- --------------------------------------------------------------------------------
Investor Relations - Gregory Riedel (508) 347-4222
GALILEO CORPORATION ACQUIRES
LEISEGANG FEINMECHANIK-OPTIK GmbH & CO. KG
- --------------------------------------------------------------------------------
STURBRIDGE, MA, - OCTOBER 8, 1997 - Galileo Corporation (NASDAQ, National
Market: GAEO) announced today the acquisition of Leisegang Feinmechanik-Optik
GmbH & Co. KG ("Leisegang GmbH"). Galileo acquired all the outstanding shares of
Leisegang GmbH for approximately US$2,250,000 in cash.
Leisegang GmbH, located in Berlin, Germany, is a privately-held manufacturer and
distributor of colposcopes and accessories. These diagnostic products are sold
to OB/GYN doctors' offices and hospitals primarily through sales representatives
and distributors. Leisegang GmbH, the world's largest and oldest manufacturer of
colposcopes, has annual sales of approximately US$3,000,000.
Galileo acquired a related company, Leisegang Medical, Inc., of Boca Raton,
Florida, in 1996. Leisegang Medical is the United States distributor of
colposcopes manufactured by Leisegang GmbH and, in addition, manufactures and
distributes a broad line of medical instruments including ultrasound, laser and
electro-surgical systems, cryosurgery equipment, surgical instruments,
hysteroscopes, fetal heart monitors and vaginal specula.
5
<PAGE> 2
William T. Hanley, president and chief executive officer of Galileo, noted that
Leisegang GmbH is well-known and highly respected worldwide for its
high-quality, reliable instruments. The company's innovative designs have set
the standard for colposcopes resulting in the company's leadership position in
this market.
"The acquisition of Leisegang GmbH, along with the acquisition of Leisegang
Medical last year and the purchase of the Sani-Spec line of vaginal specula
earlier this year, is part of Galileo's strategy to play a leading role in the
medical field and in the area of women's health in particular," Hanley added. He
concluded, "With the addition of the Leisegang GmbH products to the medical
imaging and sensing products Galileo already produces, we are now offering a
very broad line of medical instruments and equipment. We expect that Leisegang
GmbH's international distribution channels and location in Germany will also
benefit our existing medical business."
Galileo develops, manufactures and markets products based on its core
fiberoptics and electro-optics technologies for applications in medical products
and instruments, telecommunication products, analytical detector instruments and
office equipment. Galileo markets its products to OEMs, through marketing
partners, and direct to end-users. Leisegang Medical, a wholly-owned subsidiary,
develops, manufactures and markets products to the women's health field. Please
visit our web site at www.galileocorp.com for additional information.
####
6
